Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on “Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?”

Bibliographische Detailangaben

Veröffentlicht in:	Clinical and molecular hepatology 2024-10, Vol.30 (4), p.970
Hauptverfasser:	Dorothy Cheuk-yan Yiu, Huapeng Lin, Vincent Wai-sun Wong, Grace Lai-hung Wong, Ken Liu, Terry Cheuk-fung Yip
Format:	Artikel
Sprache:	kor
Schlagworte:	DPP4i Liver cancer Mortality Systemic therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!